Sexuality After Treatment of Diffuse Large B-cell Lymphoma: Patients' Experiences and Psychometric Testing of the Sexual Adjustment Questionnaire-Swedish Version II.
Cecilia Olsson, Anna Josse Eklund, Maria Larsson and 1 others
PMID 32804757WHAT IT FOUND
Patients treated for diffuse large B-cell lymphoma often said sexual interest and relationship closeness had declined.
Nurses can ask survivors which area matters and whether they want support.
Key findings
01Patients reported low sexual interest: 55.1% scored below 3 on the Sexual Interest subscale, and 63.6% scored below 3 on importance of sexual activity.
02Sexual relationship items showed negative impact: all had mean scores below 3, but only 44.6% scored below 3 on the subscale.
03Being male, younger, in a relationship, and without comorbidities were associated with higher sexual interest; being male, younger, and without comorbidities were associated with higher total sexual adjustment.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The response rate was 25%, and nonparticipants were 2.6 years older than participants. The study was cross-sectional, so it cannot show that cancer or any treatment caused the reported sexual changes. Patients received chemotherapy, chemoimmunotherapy, and/or radiotherapy, and the study did not separate the contribution of each treatment. The sample was Swedish and limited to patients aged 45 years or older with diffuse large B-cell lymphoma. Some patients could not distinguish whether changes were due to having cancer or having treatment. The questionnaire was tested only in this group and not in other cancer diagnoses.
Declared interests
The supplied text does not report funding or conflicts of interest.
The easy way to misread this
Do not conclude that chemotherapy, chemoimmunotherapy, or radiotherapy caused these sexual changes. This cross-sectional survey measured experiences after treatment and did not separate the contribution of each treatment.